Addiction and the Making of Professional Careers

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

ISBN: 9781412845977 | 1412845971
Cover: Hardcover
Copyright: 7/15/2012

Rent

(Recommended)

$75.34

Term

Due

Price

Semester

Dec 13

$79.31

Quarter

Aug 16

$75.34

Short Term

Jul 7

$71.38

*This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.
Buy New

Usually Ships in 3-5 Business Days

$108.36
eBook

Available Instantly

Online: 180 Days

Downloadable: 180 Days

$32.77

The misuse of drugs continues to cause suffering and worldwide economic turmoil. In response to these problems, many have devoted their lives to preventing the misuse of mind-altering substances. Addiction and the Making of Profession Careers focuses on the need for enhanced understanding of professional careers in the addiction field. The spectrum of professionals involved is wide and includes treatment personnel of every kind. Some of the questions examined here include: Why do some people decide to dedicate their lives to responding to drug problems? How do and should we select, train, mentor, support, inspire, and nurture the young career aspirant? What makes for the most effective use of talent? Is every personal case different or can general conclusions be reached? After a foreword by William Miller and an introduction by Griffith Edwards, the book includes interviews with Joseph Brady, Louis Harris, Conan Kornetsky, and Robert DuPont, all of whom were pioneers in the behavioral pharmacological analysis of addiction. Commentary chapters are written by Kerstin Stenius, Ilana Crome, Peter Anderson, and Jonathan Chick.

Foreword	p. xi
Acknowledgments	p. xiii
Introduction: Careers Set Questions	p. 1
Addiction Careers and Administration at a High Level
Conversation with Robert L. DuPont, MD., President of the Institute for Behavior and Health, Inc. Rockville, MD, USA and Clinical Professor of Psychiatry, Georgetown University School of Medicine, Washington, DC, USA. (Interviewed by Barry Brown) p10
Conversation with Richard Fuller, MD, Retired (Interviewed	p. 16
Conversation with Cees Goos, MD., Consultant, Anton Proksch Institute, Vienna, Austria. (Interviewed	p. 23
Conversation with Enoch Gordis, MD., Retired (Interviewed	p. 30
Conversation with Leland H. Towle, SM (MIT), Retired (Interviewed	p. 37
Commentary by Peter Anderson, MD, PhD, MPH., Professor, Alcohol and Health, Faculty of Health Medicine and Life Sciences, Maastricht, Netherlands	p. 44
Laboratory Life: The Making of Addiction Pharmacology and Behavioural Pharmacology
Conversation with Joseph V. Brady, PhD., Formerly Director, Behavioral Biology Research Center, John Hopkins Medicine, Baltimore, MD, USA (Deceased 29 July 2011).(Interviewed	p. 52
Conversation with E. A. Carlini, MD., Professor, Federal University of Sao Paulo, Sao Paulo, Brazil. (Interviewed	p. 58
Conversation with Lou Harris, PhD., Harvey Haag Professor, Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond VA, USA. (Interviewed	p. 64
Conversation with Conan Kornetsky, PhD., Professor, Departments of Psychiatry and Pharmacology, Boston University School of Medicine, Boston, Massachusetts, USA.(Interviewed	p. 71
Conversation with Michael Kuhar, PhD., Chandler Professor of Neuropharmacology, Georgia Research Alliance Eminent Scholar, Yerkes/Emory University, Atlanta GA, USA. (Interviewed	p. 79
Conversation with Malcolm H. Lader, MD., PhD., FMedSci., Emeritus Professor of Clinical Psychopharmacology, Institute of Psychiatry, Kings College London, UK. (Interviewed	p. 86
Conversation with Raphael Mechoulam, PhD., Emeritus Professor, Hebrew University, Institute for Drug Research, Medical Faculty, Institute for Drug Research, Ein Kerem Campus, Jerusalem, Israel. (Interviewed	p. 93
Conversation with Charles R. Schuster, PhD, Formerly Distinguished Professor Emeritus, Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine USA (Deceased 21 February 2011). (Interviewed	p. 100
Conversation with Tomoji Yanagita, MD., Professor and Director of the Central Laboratory for Experimental Animals, Kawasaki, Japan. (Interviewed	p. 107
Commentary by Jerome H. Jaffe, MD., Clinical Professor, Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, Baltimore, Maryland, USA.	p. 114
Clinicians and Clinical Scientists
Conversation with Timothy Cook, MA, Formerly Director, London and City Parochial Charities, London, UK. (Interviewed	p. 126
Conversation with Hamid Ghodse, MD., PhD., BSc, Emeritus Professor of Psychiatry and International Drug Policy and Director, International Centre for Drug Policy, St George's University of London, London, UK. ? (Interviewed by Andrew Johns)	p. 133
Conversation with Nick Heather, PhD., Emeritus Professor of Alcohol and Other Drug Studies, Department of Psychology, School of Life Sciences, Northumbria University, Newcastle upon Tyne, UK. (Interviewed	p. 140
Conversation with Martin Jarvis, PhD., Emeritus Professor of Health Psychology, Department of Epidemiology & Public Health, University College London, London, UK. (Interviewed	p. 147
Conversation with Jim Orford, PhD., Emeritus Professor, School of Psychology, University of Birmingham, Edgbaston, Birmingham, UK. (Interviewed	p. 154
Conversation with Shanthi Ranganathan, MD. Founder and Hon Secretary, T. T. Ranganathan Clinical Research Foundation, TTK Hospital, Chennai, India. (Interviewed	p. 162
Conversation with Bruce Ritson, MD, Formerly Consultant and Hon Senior Lecturer, Royal Edinburgh Hospital, UK. (Interviewed	p. 168
Conversation with Michael A. H. Russell, MA, MAppSci, PhD. Formerly Professor of Addiction, Institute of Psychiatry, London, UK. (Deceased 16 July 2009) (Interviewed	p. 176
Conversation with Hiroshi Suwaki, MD., Consultant, Honorary Professor of Kagawa University, Incorporated Medical Institution, Sankou Psychiatric Hospital, Kagawa, Japan. (Interviewed	p. 183
Conversation with Ambros Uchtenhagen, MD., PhD., Emeritus Professor of Social Psychiatry at Zurich University, Chair, Addiction and Public Health Research Foundation at Zurich University, Research Institute for Public Health and Addiction, Zurich, Switzerland. (Interviewed	p. 191
Commentary by liana Crome, MD, FRCPsych, Formerly Professor of Addiction Psychiatry and Academic Director of Psychiatry, Keele University Medical School, Consultant, Addiction Psychiatrist, South Staffordshire and Shropshire Healthcare NHS Foundation Trust, St George's Hospital, Stafford, UK.
Careers in Social Science and Epidemiology
Conversation with M. Douglas Anglin, PhD., Professor in Residence, Associate Director, Integrated Substance Abuse Programs, University of California, Los Angeles, California, USA. (Interviewed by Richard Rawson)	p. 208
Conversation with Walter Clark, PhD, Senior Scientist, Alcohol Research Group, Berkeley, California, USA. (Interviewed	p. 216
Conversation with Joseph Gusfield, PhD., Chair of the Sociology Department, University of California, La Jolla, California, USA. (Interviewed	p. 222
Conversation with Ragnar Hauge, Cand.Jur., former Director of the National Institute of Alcohol and Drug Research, Oslo, Norway. (Interviewed	p. 229
Conversation with Harold Holder, PhD, Senior Scientist Emeritus, Prevention Research Center, Pacific Institute for Research and Evaluation, El Cerrito, California, USA. (Interviewed	p. 236
Conversation with Rudolf Moos, PhD., Professor Emeritus, Department of Psychiatry, Stanford University, Palo Alto, California, USA. (Interviewed	p. 243
Conversation with Juha Partanen, PhD, Formerly Professor and Director, Social Research Institute for Alcohol Studies, Helsinki, Finland. (Interviewed	p. 251
Commentary by Kerstin Stenius, PhD., Editor-in-Chief, Nordisk Alkohol-och Narkotikatidskrift (Nordic Studies on Alcohol and Drugs), Helsinki, Finland; Professor, Centre for Social Research on Alcohol and Drugs, Stockholm University, Stockholm, Sweden.	p. 258
Clinicians and Clinical Research: American Contributions
Conversation with Sheila Blume, MD., Former Medical Director, Addiction and Compulsive Gambling Services, South Oaks Hospital, Amityville, New York, USA. (Interviewed	p. 266
Conversation with Roger E. Meyer, MD., Professor of Psychiatry, Penn State University Hershey Medical Center, Hershey, PA, USA. (Interviewed	p. 273
Conversation with William R. Miller, PhD., Emeritus Distinguished Professor of Psychology and Psychiatry, University of New Mexico, New Mexico, USA. (Interviewed	p. 281
Conversation with George Vaillant, MD., Professor of Psychiatry, Harvard Study of Adult Development, Boston, Massachusetts, USA. (Interviewed	p. 287
Conversation with William L. White, MA., Senior Research Consultant, Chestnut Health Systems, Lighthouse Institute, Illinois, USA. (Interviewed	p. 294
Commentary by Jonathan Chick, MA (Cantab), MPhil, DSc, FRCPE, FRCPsych., Honorary Professor, School of Health Sciences, Queen Margaret University,. Edinburgh, United Kingdom.	p. 301
Addiction Careers: Catalysts for an Interdisciplinary Field
Thomas F. Babor, PhD, MPH. Associate Editor-in-Chief, Addiction; Regional Editor for Addiction, US Office; Professor and Chairman, Department of Community Medicine & Health Care, University of Connecticut School of Medicine, Farmington, Connecticut, USA.	p. 307
Index	p. 319
Table of Contents provided by Ingram. All Rights Reserved.

Please wait while the item is added to your bag...

FREE SHIPPING

Amazon no longer offers textbook rentals. We do!

Addiction and the Making of Professional Careers

Summary

Table of Contents

Supplemental Materials